Bothwell Engineering Inc. is a network of engineering consultants dedicated to serving the pharmaceutical, biotech, cell, and gene therapy industries with innovative solutions since 2011. With a commitment to prioritizing clients and team members, their slogan, "Optimizing patient care by putting our clients and team members first," underscores their values. The company offers a range of services, including facility startup, commissioning, validation, project management, manufacturing and process engineering solutions, automation engineering, operational readiness, and quality engineering to clients in the biotechnology and pharmaceutical sectors.
One of the distinctive factors of BEI is its consultants' extensive industry experience, which averages 36,000 hours (18 years) and often surpasses 50,000 hours per member, providing Greater Than Value advantages to their clients. The company's expertise extends to supporting capital projects such as facility start-ups, suite upgrades, building retrofits, large-scale technology transfer, ongoing manufacturing campaigns, and commissioning new equipment and facilities in various areas. Their engineers have gained vast experience in the biotechnology and pharmaceutical industries, having completed projects across Europe and the US.
Despite the absence of recent investments, Bothwell Engineering Inc. offers a compelling proposition to potential investors due to its established market presence, strong industry network, and proven track record in delivering cutting-edge solutions to the biotechnology and pharmaceutical sectors. With a focus on advancing patient care through their exceptional services, BEI presents an attractive opportunity for investors seeking to support companies dedicated to making a meaningful impact in the healthcare industry.